BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17950880)

  • 21. New Therapies in Veterinary Oncology.
    Mullin C; Clifford CA; Johannes CM
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):469-476. PubMed ID: 38184436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future of veterinary radiation oncology.
    Gavin PR
    Vet Clin North Am Small Anim Pract; 1997 Jan; 27(1):157-65. PubMed ID: 9002175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIK3CA mutations matter for cancer in dogs.
    Kim JH
    Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species differences in tumour responses to cancer chemotherapy.
    Lawrence J; Cameron D; Argyle D
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Therapies in Veterinary Oncology.
    Londhe P; Gutwillig M; London C
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):917-931. PubMed ID: 31186124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
    Gordon I; Paoloni M; Mazcko C; Khanna C
    PLoS Med; 2009 Oct; 6(10):e1000161. PubMed ID: 19823573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The many challenges of veterinary oncology.
    Kidd C
    Can Vet J; 2008 Nov; 49(11):1132-5. PubMed ID: 19183739
    [No Abstract]   [Full Text] [Related]  

  • 28. Flow cytometry in veterinary oncology.
    Reggeti F; Bienzle D
    Vet Pathol; 2011 Jan; 48(1):223-35. PubMed ID: 20826845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology.
    London CA; Gardner H; Zhao S; Knapp DW; Utturkar SM; Duval DL; Chambers MR; Ostrander E; Trent JM; Kuffel G
    Vet Comp Oncol; 2023 Dec; 21(4):565-577. PubMed ID: 37778398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combretastatin A4-phosphate and its potential in veterinary oncology: a review.
    Abma E; Daminet S; Smets P; Ni Y; de Rooster H
    Vet Comp Oncol; 2017 Mar; 15(1):184-193. PubMed ID: 25988493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine Cancer Genomics: Lessons for Canine and Human Health.
    Ostrander EA; Dreger DL; Evans JM
    Annu Rev Anim Biosci; 2019 Feb; 7():449-472. PubMed ID: 30418802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in veterinary radiation oncology.
    Kent MS; Turek MM; Farrelly J
    Vet Comp Oncol; 2018 Jun; 16(2):167-169. PubMed ID: 29333737
    [No Abstract]   [Full Text] [Related]  

  • 33. The evolution of veterinary surgical oncology.
    Withrow SJ
    Clin Tech Small Anim Pract; 1998 Feb; 13(1):1-3. PubMed ID: 9634340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging in veterinary oncology: exciting new developments.
    Freeman L
    Vet J; 2013 Sep; 197(3):523-4. PubMed ID: 23886702
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of post-genomic techniques in dog cancer research.
    Ceciliani F; Roccabianca P; Giudice C; Lecchi C
    Mol Biosyst; 2016 Aug; 12(9):2665-79. PubMed ID: 27345606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taking on cancer: treatment increases, improves for companion animals.
    Burns K
    J Am Vet Med Assoc; 2014 Jan; 244(2):140-4. PubMed ID: 24378021
    [No Abstract]   [Full Text] [Related]  

  • 37. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.
    Patil SS; Gentschev I; Nolte I; Ogilvie G; Szalay AA
    J Transl Med; 2012 Jan; 10():3. PubMed ID: 22216938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naturally occurring cancers in dogs: insights for translational genetics and medicine.
    Alvarez CE
    ILAR J; 2014; 55(1):16-45. PubMed ID: 24936028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of organic near-infrared fluorescent contrast agents in image-guided oncologic procedures and its potential in veterinary oncology.
    Favril S; Abma E; Blasi F; Stock E; Devriendt N; Vanderperren K; de Rooster H
    Vet Rec; 2018 Sep; 183(11):354. PubMed ID: 29705740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic margins and the residual tumour classification scheme: Is it time to use a validated scheme in human oncology to standardise margin assessment in veterinary oncology?
    Liptak JM
    Vet Comp Oncol; 2020 Mar; 18(1):25-35. PubMed ID: 31749262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.